# data[].attributes.body
Eren Özmen-Nasa’ya Uzay Aracı Yapan Türk’ün Hikayesi
- In 1981 he went to learn English from Turkey to America.
- After school, he worked as an accountant in a company.
- In 1988, he joined a company called Sierra Nevada.
- A few years later, he bought the company, which has 20 employees, together with his wife, due to his contribution to the growth of the company.
- To buy the company, he sold the house where he and his wife Fatih Özmen lived.
- The company is currently to NASA spacecraft to make Turkey also has 4,000 employees and is among the countries!
- 1981'de Türkiye'den Amerika'ya İngilizce öğrenmek için gitti.
- Okuldan sonra bir şirkette muhasebeci olarak çalıştı.
- 1988'de Sierra Nevada adlı bir şirkete katıldı.
- Birkaç yıl sonra 20 çalışanı olan şirketi eşiyle birlikte şirketin büyümesine katkılarından dolayı satın aldı.
- Şirketi satın almak için eşi Fatih Özmen ile birlikte yaşadığı evi sattı.
- Şirket şu anda NASA'ya uzay aracı yapmak için Türkiye'yi de 4.000 çalışanıyla ve ülkeler arasında yer alıyor!

# data[].attributes.body
Çin’in 5G Teknolojisindeki Türk Etkisi  Profesör Erdal Arıkan
Did you know that a Turkish professor is vital in the race to implement 5G technology in China and America? The name of this professor is Erdal Arıkan, and with a formula he found, he broke new ground in the world and made the whole world talk about himself.
Çin ve Amerika 5G teknolojisini hayata geçirme yarışında bir Türk profesörün hayati önem sahip olduğunu biliyor muydunuz? Bu profesörün adı Erdal Arıkan ve bulmuş olduğu bir formülle dünyada bir ilke imza attı ve tüm dünyaya kendinden sözettirdi.

# data[].attributes.body
Arkarası Primary School Students
Stephen Hawking
Did you know that a Turkish professor is vital in the race to implement 5G technology in China and America? The name of this professor is Erdal Arıkan, and with a formula he found, he broke new ground in the world and made the whole world talk about himself.
Çin ve Amerika 5G teknolojisini hayata geçirme yarışında bir Türk profesörün hayati önem sahip olduğunu biliyor muydunuz? Bu profesörün adı Erdal Arıkan ve bulmuş olduğu bir formülle dünyada bir ilke imza attı ve tüm dünyaya kendinden söz ettirdi.

# data[].attributes.headline
Samet Cebeci- Kartal Science and Art Centre

# data[].attributes.subject
Samet Cebeci- Kartal Science and Art Centre

# data[].attributes.body
Uğur Şahin was born on September 29, 1965 in İskenderun, in the Hatay province, Turkey. He moved with his mother to Germany at the age of four to live with his father, who worked in Cologne's Ford factories. Besides football, he was interested in popular science books, which he borrowed from the Catholic church library. Initially, his primary school teacher recommended that he attend a hauptschule, which would not have readily enabled him to attend university; upon intervention of his German neighbour, he went to a gymnasium instead.He graduated from the Erich-Kästner-Gymnasium in Cologne-Niehl in 1984, the first child at the school with Turkish guest worker parents. He took advanced courses in mathematics and chemistry.

Şahin met his future wife, Özlem Türeci, during his work at the Saarland University Hospital (Universität des Saarlandes) in Homburg, where Türeci completed her last year of studies. The couple married in 2002; they have one daughter.

He and his spouse are among the hundred wealthiest people in Germany. As of May 2021, Bloomberg Billionaires Index estimated his net worth at US$ 8.35 billion.

Education
Şahin studied medicine at the University of Cologne from 1984 to 1992.He received his doctorate in 1992 with a thesis on immunotherapy for tumor cells (bispecific monoclonal antibodies for the activation of cytostatic precursors on tumor cells), which was graded summa cum laude. His thesis supervisor was Michael Pfreundschuh [de]. From 1992 to 1994, he studied mathematics at the Fernuniversität Hagen.

Career
Şahin worked as a physician for internal medicine and hematology/oncology from 1991 to 2000 at the University Hospital of Cologne [de] and then at the Saarland University Hospital in Homburg. He habilitated in 1999 in the field of molecular medicine and immunology. After working at the Institute for Experimental Immunology of the University Hospital of Zürich in 2000, he moved to the University Medical Center Mainz. There, he has been working in various leading positions in cancer research and immunology since 2001 and has been a professor for experimental oncology at the III. medical clinic since 2006.

Şahin works on identifying and characterizing new target molecules (antigens) for the immunotherapy of cancer tumors, e.g. breast cancer, prostate cancer, lung cancer, and other dangerous cancers. The aim is to develop a cancer vaccine based on ribonucleic acid (RNA), a messenger substance with genetic information that triggers a corresponding reaction of the immune system, leading to the inhibition and regression of tumors. These RNA vaccines do not cause a permanent genetic change in the genetic material of the cells. However, they are, in simple terms, dissolved again after "single-use" to form a protein. One problem is to develop a genetic engineering process so that these vaccines trigger a direct and targeted response from the immune system after injection. In developing such optimized RNA chains, Uğur Şahin and his research team have achieved remarkable success in recent years.

Şahin sees himself as an immune engineer who tries to use the body's antiviral mechanisms to treat, for example, cancer when the immune system is otherwise unable to fight it. He sees his vision in guiding the immune system to "protect us from or alleviate certain diseases."

University Medical Center Mainz
In 2000, Şahin became head of the junior research group of the SFB 432 of the University Medical Center Mainz [de], and in 2003 chair of the Tumor Vaccine Center.Since 2006 he has been a private lecturer in the Department of Experimental and Translational Oncology. In 2010, he was the founder of Translational Oncology at the University Medical Center of Johannes Gutenberg University Mainz (TRON). This is a biopharmaceutical research institute that develops new diagnostic tools and drugs to treat cancer and other diseases with a high unmet medical need. Its focus is on individualized medicine and cancer immunotherapy. From its foundation until September 2019, he was its scientific director.Since then, he has been working as a scientific advisor and supervisor of Ph.D. students.For his work in this field, Şahin was awarded the German Cancer Prize [de]. He is deputy director of the University Center for Tumor Diseases Mainz (UCT Mainz), founded in 2011. The UCT Mainz is an association of all oncologically active institutions of the University Medical Center Mainz that focus on clinical oncology or oncological research. In 2017, it was involved in establishing the new Helmholtz Institute HI-TRON, which is a cooperation between the German Cancer Research Center (DKFZ) and TRON. He is one of the scientific directors of the new Helmholtz Institute.During the founding ceremony, Şahin declared that he believes "cancer can be defeated in the future."

# data[].attributes.body
UĞUR ŞAHİN
Born in İskenderun, Prof. Dr. Uğur Şahin received the title of 93rd rich man in Germany, where he went when he was 4 years old with a fortune of 3.9 billion dollars. Uğur's company, BionTech, achieved great success in the coronavirus vaccine they developed with US-based Pfizer. Here's what you need to know about BioNTech founder Uğur Şahin ...
As the CEO of BioNTech, Prof. Uğur Şahin was born in Hatay. 55-year-old Şahin was previously serving as the Scientific Advisory Board Chairman of the pharmaceutical company Ganymed, of which he co-founded with his wife. Uğur Şahin also works at the Mainz University Medical Center.
Şahin, an immunologist and oncologist, was born in Iskenderun and immigrated to Germany with his family at the age of four.
Şahin, whose father worked at the Ford factory in Cologne, dreamed of becoming a doctor. Şahin, who made this dream come true for the child of a factory worker, is among the 100 richest people in Germany with his wife today. The couple had sold their first company, Ganymed, for 1.4 billion euros, according to the British Telegraph newspaper.
He employs around 80 scientists at his BionTech company. Dr. Uğur Şahin received the title of 93rd rich man in Germany, where he went when he was 4 years old with a fortune of 3.9 billion dollars.
İskenderun doğumlu, Prof. Dr. Uğur Şahin, 3,9 milyar dolarlık servetiyle 4 yaşındayken gittiği Almanya'nın 93'üncü zengini unvanını aldı. Uğur'un şirketi BionTech, ABD merkezli Pfizer ile geliştirdikleri koronavirüs aşısında büyük başarı sağladı. İşte, BioNTech kurucusu Uğur Şahin hakkında bilinmesi gerekenler... BioNTech'in CEO'su olan Prof. Uğur Şahin, Hatay doğumlu. 55 yaşındaki Şahin, daha önce de eşiyle birlikte kurucusu olduğu Ganymed adlı ilaç şirketinin Bilimsel Tavsiye Kurulu Başkanı olarak görev yapıyordu. Uğur Şahin, aynı zamanda Mainz Üniversitesi Tıp Merkezi'nde çalışıyor. İmmünolog ve onkolog olan Şahin, İskenderun'da doğduktan sonra dört yaşında ailesiyle birlikte Almanya'ya göçmüştü. Babası Köln'deki Ford fabrikasında çalışan Şahin'in hayali doktor olmaktı. Bir fabrika işçisinin çocuğu için ulaşması zor bu hayali gerçek kılan Şahin, bugün eşiyle birlikte Almanya'nın en zengin 100 kişisi arasında. İngiliz Telegraph gazetesine göre çift, ilk şirketleri Ganymed'i 1,4 milyar euroya satmıştı. Sahibi olduğu BionTech şirketinde 80 civarında bilim insanı çalıştıran Prof. Dr. Uğur Şahin, 3,9 milyar dolarlık servetiyle 4 yaşındayken gittiği Almanya'nın 93'üncü zengini unvanını aldı. hakkında daha fazla bilgi